Resveratrol 用于 Cerebrovascular Health
CResearch suggests resveratrol may improve cerebral blood flow through nitric oxide-mediated vasodilation and activation of neuroprotective SIRT1 pathways. Bioavailability remains a key challenge.
结论
Research suggests resveratrol may improve cerebral blood flow through nitric oxide-mediated vasodilation and activation of neuroprotective SIRT1 pathways. Bioavailability remains a key challenge.
Key Study Findings
研究人群: experimental models and clinical trials on Alzheimer's, Parkinson's, and multiple sclerosis
研究人群: older adults and individuals with neurodegenerative disorders
研究人群: PC12 rat pheochromocytoma cells
研究人群: None
研究人群: CLP-induced sepsis-associated encephalopathy mice
研究人群: Menopausal women
Key Statistics
8
研究数量
600
受试者
Positive
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 150-500 mg/day trans-resveratrol
- cognitivesupport:
- 200-500 mg/day
上限: 5,000 mg/day (highest dose in clinical trials)
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| 40 or 60 mg/kg | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| 250 mg single dose | -- | Positive | 16 |
最佳服用时间: With meals containing fat; morning preferred
Safety & Side Effects
已报告的副作用
- ⚠ Gastrointestinal discomfort
- ⚠ Headache
- ⚠ Diarrhea at high doses
已知相互作用
- ● Anticoagulants (may increase bleeding risk)
- ● CYP450 substrates (affects drug metabolism)
- ● Estrogen-sensitive conditions (weak estrogenic activity)
可耐受最高摄入量: 5,000 mg/day (highest dose in clinical trials)
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Resveratrol help with Cerebrovascular Health?
How much Resveratrol should I take for Cerebrovascular Health?
Are there side effects of Resveratrol?
How strong is the evidence for Resveratrol and Cerebrovascular Health?
Related Evidence
其他成分用于 Cerebrovascular Health
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。